Oxaliplatin With Gemcitabine in Patients With Carcinoma of the Urothelial Tract
Status:
Terminated
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
This is a phase II monocentric study of oxaliplatin (Ox) in combination with gemcitabine
(Gem; GEMOX) in patients (pts) with advanced/metastatic transitional cell carcinoma (TCC) of
the urothelial tract.